Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 162


Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.

Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland WF, Giedl C, Hofstädter F, Rubenwolf P, Burger M, Aziz A.

Urol Int. 2014;93(3):311-9. doi: 10.1159/000360483. Epub 2014 Sep 4.


The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.

Mayr R, May M, Burger M, Martini T, Pycha A, Dechet C, Lodde M, Comploj E, Wieland WF, Denzinger S, Otto W, Aziz A, Fritsche HM, Gierth M.

Urol Int. 2014;93(3):303-10. doi: 10.1159/000362421. Epub 2014 Aug 19.


Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focused ultrasound (HIFU) for localised prostate cancer.

Ganzer R, Bründl J, Koch D, Wieland WF, Burger M, Blana A.

World J Urol. 2015 Jan;33(1):99-104. doi: 10.1007/s00345-014-1289-2. Epub 2014 Apr 3.


Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancer.

Hitzenbichler F, Stoehr CG, Rogenhofer M, Wieland WF, Ruemmele P, Hartmann A, Stoehr R.

Pathobiology. 2014;81(2):53-9. doi: 10.1159/000355976. Epub 2013 Nov 9.


Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database.

Aziz A, May M, Zigeuner R, Pichler M, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Fenske F, Sountoulides P, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Wieland WF, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Brookman-May S; Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group.

J Urol. 2014 Feb;191(2):310-5. doi: 10.1016/j.juro.2013.08.021. Epub 2013 Aug 20.


Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients.

Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F.

Clin Genitourin Cancer. 2013 Dec;11(4):537-44. doi: 10.1016/j.clgc.2013.05.001. Epub 2013 Jul 10.


Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.

Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A, Burger M.

Urol Int. 2013;91(1):97-102. doi: 10.1159/000350232. Epub 2013 Jun 6.


Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M.

World J Urol. 2014 Apr;32(2):365-71. doi: 10.1007/s00345-013-1105-4. Epub 2013 Jun 5.


Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent prostate cancer foci.

Bründl J, Schneider S, Weber F, Zeman F, Wieland WF, Ganzer R.

Eur Urol. 2014 Apr;65(4):802-8. doi: 10.1016/j.eururo.2013.04.043. Epub 2013 May 7.


Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients.

Stoehr R, Taubert H, Gaisa NT, Smeets D, Kneitz B, Giedl J, Ruemmele P, Wieland WF, Rau TT, Hartmann A.

J Pathol. 2013 Aug;230(4):453-6. doi: 10.1002/path.4208.


Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.

Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ.

Eur J Surg Oncol. 2013 Apr;39(4):372-9. doi: 10.1016/j.ejso.2013.02.009.


Comparison of transrectal prostate biopsy results with histology of transurethral resection of the prostate in men undergoing high-intensity focused ultrasound.

Rogenhofer S, Walter B, Hartmann A, Wieland WF, Mueller SC, Blana A.

Urol Int. 2013;90(3):283-7. doi: 10.1159/000346320. Epub 2013 Feb 13.


Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.

Buse S, Höfner T, Müller SC, Hermann E, Wieland WF, May M, Stief CG, Bastian PJ, Hohenfellner M, Haferkamp A.

Int J Urol. 2013 Sep;20(9):866-71. doi: 10.1111/iju.12073. Epub 2013 Feb 4.


Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.

Ganzer R, Fritsche HM, Brandtner A, Bründl J, Koch D, Wieland WF, Blana A.

BJU Int. 2013 Aug;112(3):322-9. doi: 10.1111/j.1464-410X.2012.11715.x. Epub 2013 Jan 28.


A patient with fibroepithelial polyp of the ureter-a rare condition mimicking malignancy: a case report.

Brummeisl W, Fritsche HM, Huber E, Wieland WF, Ganzer R.

Case Rep Urol. 2012;2012:901693. doi: 10.1155/2012/901693. Epub 2012 Dec 27.


Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.

May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S.

BJU Int. 2013 Aug;112(4):E383-90. doi: 10.1111/j.1464-410X.2012.11735.x. Epub 2013 Jan 10.


Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.

Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M.

Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.


Body mass index has no impact on sperm quality but on reproductive hormones levels.

M Al-Ali B, Gutschi T, Pummer K, Zigeuner R, Brookman-May S, Wieland WF, Fritsche HM, Aziz A.

Andrologia. 2014 Mar;46(2):106-11. doi: 10.1111/and.12051. Epub 2012 Nov 24.


NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.

Stoehr CG, Nolte E, Wach S, Wieland WF, Hofstaedter F, Hartmann A, Stoehr R.

Int J Mol Sci. 2012;13(9):10959-69. doi: 10.3390/ijms130910959. Epub 2012 Jul 26.


Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders' grading of penile squamous cell carcinomas.

Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M.

Urol Int. 2013;90(2):207-13. doi: 10.1159/000342639. Epub 2012 Oct 26.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk